Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH
VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 05/26/17

    • 30-Day SEC Yield1

      1.57%
    • Total Net Assets

      $307.6M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2017
  • Portfolio Composition (%)
    as of 05/26/17

    • % of Net Assets
    • Stocks

      99.98
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.02
  • Download All HoldingsDaily Holdings (%) as of 05/26/17

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    211,332
    26,822,2578.72
    Novartis Ag
    NVS US
    235,187
    18,963,1286.17
    Astrazeneca Plc
    AZN US
    505,008
    17,094,5215.56
    Novo Nordisk A/S
    NVO US
    405,311
    16,893,3625.49
    Sanofi
    SNY US
    343,243
    16,818,9075.47
    Zoetis Inc
    ZTS US
    252,207
    15,790,6805.13
    Glaxosmithkline Plc
    GSK US
    361,100
    15,408,1375.01
    Abbvie Inc
    ABBV US
    231,557
    15,296,6554.97
    Pfizer Inc
    PFE US
    463,559
    14,898,7864.84
    Merck & Co Inc
    MRK US
    225,715
    14,653,4184.76
    Mckesson Corp
    MCK US
    90,425
    14,576,5104.74
    Bristol-Myers Squibb Co
    BMY US
    260,018
    14,033,1714.56
    Amerisourcebergen Corp
    ABC US
    150,053
    13,654,8234.44
    Shire Plc
    SHPG US
    75,087
    13,303,9154.33
    Eli Lilly & Co
    LLY US
    160,263
    12,508,5274.07
    Mylan Nv
    MYL US
    307,501
    12,213,9403.97
    Perrigo Co Plc
    PRGO US
    169,384
    11,848,4113.85
    Teva Pharmaceutical Industries Ltd
    TEVA US
    407,156
    11,603,9463.77
    Jazz Pharmaceuticals Plc
    JAZZ US
    53,602
    8,099,7982.63
    Valeant Pharmaceuticals International I
    VRX US
    443,898
    5,695,2111.85
    Mallinckrodt Plc
    MNK US
    109,684
    4,747,1241.54
    Patterson Cos Inc
    PDCO US
    91,514
    4,021,1251.31
    Akorn Inc
    AKRX US
    104,182
    3,459,8841.12
    Gw Pharmaceuticals Plc
    GWPH US
    26,384
    2,800,1340.91
    Endo International Plc
    ENDP US
    176,717
    2,318,5270.75
    Other/Cash
    --
    --
    49,6530.02
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.